Crossbridge Bio

Developer of Antibody-Drug Conjugate therapeutics

placeHouston, Texas, United States calendar_todayFounded 2023 language crossbridgebio.com

Social engagement

Social engagement: 2.7K social following, 5 posts in the last 12 months — below the industry typical range.

Investor mix

6 investors on record; lead investors include TMC Venture Fund, CE Ventures, Crescent Enterprises.

Investor typeCountShare
Venture capital350%
Accelerator & incubator117%
Other / undisclosed233%

Recent activity

7 Nov 2025
Recognition
15 Oct 2025
Event
ESMO conference
5 Sep 2025
Event
ADC Partnering event
Coming soon